{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:35:55Z","timestamp":1762432555191,"version":"3.41.0"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021771","name":"Tabriz University of Medical Sciences Student Research Committee","doi-asserted-by":"publisher","award":["72272"],"award-info":[{"award-number":["72272"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.exer.2025.110416","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:01:28Z","timestamp":1746198088000},"page":"110416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recent advances on modeling retinal disease: Towards efficient gene\/drug therapy"],"prefix":"10.1016","volume":"256","author":[{"given":"Elham","family":"Norouz Dolatabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Akbarzadeh Zaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Hashim Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Eftekhari Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helder","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-0896","authenticated-orcid":false,"given":"Effat","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib1","article-title":"Mathematical modeling and analysis of diabetic retinopathy","volume":"13","author":"Aadesh","year":"2021","journal-title":"International Journal of Pharmaceutical Research (09752366)"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/jop.2013.0063","article-title":"Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model","volume":"29","author":"Abarca","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"year":"2021","series-title":"Finite Element Modelling of Retinal Detachment","author":"Aboulatta","key":"10.1016\/j.exer.2025.110416_bib3"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/stem.1885","article-title":"Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma","volume":"33","author":"Abu-Hassan","year":"2015","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1479164116683149","article-title":"Retinal pathology is associated with increased blood\u2013retina barrier permeability in a diabetic and hypercholesterolaemic pig model: beneficial effects of the LpPLA2 inhibitor darapladib","volume":"14","author":"Acharya","year":"2017","journal-title":"Diabetes Vasc. Dis. Res."},{"year":"2015","series-title":"Oxygen and Glucose Deprivation on Human M\u00fcller Cells (MIO-M1) and Human Organotypic Retinal Cultures (Horcs) in Relation to Glaucoma","author":"Aldarwesh","key":"10.1016\/j.exer.2025.110416_bib6"},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/biom10111579","article-title":"Acrolein: a potential mediator of oxidative damage in diabetic retinopathy","volume":"10","author":"Alfarhan","year":"2020","journal-title":"Biomolecules"},{"year":"2017","series-title":"Quantified Phenotype Analysis in a Cell Model for Autosomal Dominant Retinitis Pigmentosa","author":"Alghamdi","key":"10.1016\/j.exer.2025.110416_bib8"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/77068","article-title":"Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy","volume":"25","author":"Ali","year":"2000","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/pharmaceutics16040470","article-title":"First-year real-life experience with intravitreal faricimab for refractory neovascular age-related macular degeneration","volume":"16","author":"Aljundi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071398","article-title":"Phototoxic action spectrum on a retinal pigment epithelium model of age-related macular degeneration exposed to sunlight normalized conditions","volume":"8","author":"Arnault","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","article-title":"Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2025.110416_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4046597","article-title":"Changes in retinal function and cellular remodeling following experimental retinal detachment in a rabbit model","volume":"2017","author":"Barliya","year":"2017","journal-title":"J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020333","article-title":"Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of leber congenital amaurosis","volume":"2","author":"Batten","year":"2005","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2533\/000942905777676281","article-title":"Polymeric nanoparticles for drug delivery to the posterior segment of the eye","volume":"59","author":"Bejjani","year":"2005","journal-title":"Chimia"},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib16","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/ijms23062922","article-title":"Retinal organoids and retinal prostheses: an overview","volume":"23","author":"Bellapianta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib17","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1073\/pnas.1118847109","article-title":"Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa","volume":"109","author":"Beltran","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib18","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","article-title":"Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations","volume":"25","author":"Beltran","year":"2017","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030347","article-title":"Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of leber congenital amaurosis","volume":"3","author":"Bemelmans","year":"2006","journal-title":"PLoS Med."},{"issue":"120","key":"10.1016\/j.exer.2025.110416_bib20","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2025.110416_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fphys.2018.00989","article-title":"Estimation of diabetic retinal microaneurysm perfusion parameters based on computational fluid dynamics modeling of adaptive optics scanning laser ophthalmoscopy","volume":"9","author":"Bernabeu","year":"2018","journal-title":"Front. Physiol."},{"issue":"17","key":"10.1016\/j.exer.2025.110416_bib23","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301707RR","article-title":"Accelerated maturation of ARPE-19 cells for the translational assessment of gene therapy","volume":"38","author":"Bernd","year":"2024","journal-title":"Faseb j."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","article-title":"Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A","volume":"128","author":"Berson","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1089\/hum.2012.008","article-title":"Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat\u00ae, for age-related macular degeneration","volume":"23","author":"Binley","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2025.110416_bib26","first-page":"279","article-title":"Cellular potts model: applications to vasculogenesis and angiogenesis. Probabilistic cellular automata: theory","author":"Boas","year":"2018","journal-title":"Applications and Future Perspectives"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib27","first-page":"684","article-title":"Vitamin A and interstitial retinol-binding protein in an eye with recessive retinitis pigmentosa","volume":"26","author":"Bridges","year":"1985","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajo.2007.06.039","article-title":"Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients","volume":"144","author":"Brown","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ymthe.2006.05.019","article-title":"In contrast to AAV-Mediated cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration","volume":"14","author":"Buch","year":"2006","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.exer.2025.110416_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00439-019-01999-6","article-title":"Natural models for retinitis pigmentosa: progressive retinal atrophy in dog breeds","volume":"138","author":"Bunel","year":"2019","journal-title":"Hum. Genet."},{"key":"10.1016\/j.exer.2025.110416_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijbiomac.2020.09.234","article-title":"Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: impact on human ARPE-19 culture cells","volume":"165","author":"Buosi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exer.2025.110416_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exer.2015.06.005","article-title":"The non-human primate experimental glaucoma model","volume":"141","author":"Burgoyne","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib34","series-title":"The First Twelve Weeks of Gestation","first-page":"469","article-title":"Human and animal models: limitations and comparisons","author":"Burton","year":"1992"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/hum.2015.142","article-title":"Preclinical dose-escalation study of intravitreal AAV-RS1 gene therapy in a mouse model of X-linked retinoschisis: dose-dependent expression and improved retinal structure and function","volume":"27","author":"Bush","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00439-018-1933-9","article-title":"Application of CRISPR\/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases","volume":"137","author":"Cai","year":"2018","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav3335","article-title":"In vivo genome editing rescues photoreceptor degeneration via a Cas9\/RecA-mediated homology-directed repair pathway","volume":"5","author":"Cai","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-4835(89)90021-3","article-title":"Y-79 retinoblastoma cells: isolation and characterization of clonal lineages","volume":"48","author":"Campbell","year":"1989","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.exer.2006.01.032","article-title":"Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal recessive retinitis pigmentosa: the Rho (\u2212\/\u2212) mouse","volume":"83","author":"Campbell","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2006","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology"},{"issue":"9095","key":"10.1016\/j.exer.2025.110416_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1167\/iovs.05-0965","article-title":"RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65\u2212\/\u2212 mice","volume":"47","author":"Chen","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib46","first-page":"1","article-title":"Classification of age-related macular degeneration using convolutional-neural-network-based transfer learning","volume":"22","author":"Chen","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.exer.2025.110416_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83205","article-title":"Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects","volume":"12","author":"Chen","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib48","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s42003-022-04134-w","article-title":"Prostaglandin-based rAAV-mediated glaucoma gene therapy in brown Norway rats","volume":"5","author":"Chern","year":"2022","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib49","article-title":"Wet-AMD on a chip: modeling outer blood-retinal barrier in vitro","volume":"7","author":"Chung","year":"2018","journal-title":"Adv. Healthcare Mater."},{"issue":"13\u201314","key":"10.1016\/j.exer.2025.110416_bib50","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/hum.2020.281","article-title":"Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes","volume":"32","author":"Chung","year":"2021","journal-title":"Hum. Gene Ther."},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib51","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/genes14112093","article-title":"Global frequency analyses of canine progressive rod-cone degeneration\u2013progressive retinal atrophy and collie eye anomaly using commercial genetic testing data","volume":"14","author":"Clark","year":"2023","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib52","first-page":"1486","article-title":"CRISPR\/Cas9-based genome editing approaches for RP1 associated autosomal dominant retinitis pigmentosa","volume":"62","author":"Collin","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/cells9040931","article-title":"Mouse models of inherited retinal degeneration with photoreceptor cell loss","volume":"9","author":"Collin","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.preteyeres.2010.04.004","article-title":"Nanoparticles for retinal gene therapy","volume":"29","author":"Conley","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017376","article-title":"Gene therapy for PRPH2-associated ocular disease: challenges and prospects","volume":"4","author":"Conley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0161-6420(95)30973-6","article-title":"Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial","volume":"102","author":"Control","year":"1995","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib57","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/glia.23983","article-title":"Reproducing diabetic retinopathy features using newly developed human induced\u2010pluripotent stem cell\u2010derived retinal m\u00fcller glial cells","volume":"69","author":"Couturier","year":"2021","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/stem.3325","article-title":"NRL\u2212\/\u2212 gene edited human embryonic stem cells generate rod-deficient retinal organoids enriched in S-cone-like photoreceptors","volume":"39","author":"Cuevas","year":"2021","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0014-4835(03)00213-6","article-title":"The blood\u2013retinal barriers system. Basic concepts and clinical evaluation","volume":"78","author":"Cunha-Vaz","year":"2004","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib60","doi-asserted-by":"crossref","DOI":"10.1142\/S0219519416500603","article-title":"Finite element analysis of the mechanical characteristics of glaucoma","volume":"16","author":"Dai","year":"2016","journal-title":"J. Mech. Med. Biol."},{"key":"10.1016\/j.exer.2025.110416_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-319-29346-2_6","article-title":"Pharmacokinetics and pharmacodynamics of ocular drugs","author":"Dave","year":"2016","journal-title":"Nano-Biomaterials For Ophthalmic Drug Delivery"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib62","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1167\/iovs.16-20072","article-title":"Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides","volume":"58","author":"De Cogan","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib63","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1002\/eji.200425022","article-title":"Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis","volume":"34","author":"de Kozak","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.exer.2025.110416_bib64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejpb.2023.05.007","article-title":"Towards a population pharmacokinetic\/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration","volume":"188","author":"Del Amo","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2008.09.004","article-title":"A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors","volume":"133","author":"del Pozo-Rodr\u00edguez","year":"2009","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2011.06.005","article-title":"Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway","volume":"79","author":"Delgado","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/hum.2011.115","article-title":"Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis","volume":"23","author":"Delgado","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib68","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1167\/iovs.11-8831","article-title":"Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats","volume":"53","author":"Deng","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib69","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1167\/iovs.16-21402","article-title":"Therapeutic effects of a novel agonist of peroxisome proliferator-activated receptor alpha for the treatment of diabetic retinopathy","volume":"58","author":"Deng","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/proteomes11020012","article-title":"Oxidative stress induced dysfunction of protein synthesis in 661W mice photoreceptor cells","volume":"11","author":"Deng","year":"2023","journal-title":"Proteomes"},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib71","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s10237-020-01360-1","article-title":"A mechanical model of posterior vitreous detachment and generation of vitreoretinal tractions","volume":"19","author":"Di Michele","year":"2020","journal-title":"Biomech. Model. Mechanobiol."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021452","article-title":"A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations","volume":"6","author":"Downs","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib74","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110416_bib75","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.omtn.2018.07.010","article-title":"Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human C. 2991+ 1655A> G LCA10 models","volume":"12","author":"Dulla","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6372","key":"10.1016\/j.exer.2025.110416_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib77","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4239\/wjd.v6.i2.312","article-title":"Current knowledge on diabetic retinopathy from human donor tissues","volume":"6","author":"Eisma","year":"2015","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib78","doi-asserted-by":"crossref","DOI":"10.2174\/1874120702014010011","article-title":"Numerical computational study of photoacoustic signals from eye models to detect diabetic retinopathy","volume":"14","author":"ElGohary","year":"2020","journal-title":"Open Biomed. Eng. J."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib79","first-page":"1968","article-title":"Efficacy of a 6 month sustained hydrogel delivery system for tyrosine kinase inhibitors in a VEGF induced retinal leakage model","volume":"58","author":"Elhayek","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib80","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib81","first-page":"506","article-title":"NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells","volume":"10","author":"Emerich","year":"2008","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.exer.2025.110416_bib82","unstructured":"Etzrodt J, Krishna-K K, Redies C. Expression of Classic Cadherins and \u03b4-protocadherins in the Developing Ferret Retina."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib83","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/02713683.2016.1193615","article-title":"Functional and structural evaluation of sildenafil in a rat model of acute retinal ischemia\/reperfusion injury","volume":"42","author":"Ezra-Elia","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib84","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1096\/fj.09-151084","article-title":"Structural insights into retinitis pigmentosa from unfolding simulations of rhodopsin mutants","volume":"24","author":"Fanelli","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2025.110416_bib85","first-page":"1097","article-title":"Transplantation of subretinal stem cell-derived retinal pigment epithelium for STARGARDT\u2019S disease: a phase I clinical trial","volume":"10","author":"Fernandes","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.exer.2025.110416_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnana.2018.00055","article-title":"Retinal vascular degeneration in the transgenic P23H rat model of retinitis pigmentosa","volume":"12","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2018","journal-title":"Front. Neuroanat."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/cells5040044","article-title":"Potential of induced pluripotent stem cells (iPSCs) for treating age-related macular degeneration (AMD)","volume":"5","author":"Fields","year":"2016","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib88","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1038\/srep06501","article-title":"Establishment of an experimental ferret ocular hypertension model for the analysis of central visual pathway damage","volume":"4","author":"Fujishiro","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110416_bib89","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1109\/ACCESS.2018.2888639","article-title":"Diagnosis of diabetic retinopathy using deep neural networks","volume":"7","author":"Gao","year":"2018","journal-title":"IEEE Access"},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib90","first-page":"2552","article-title":"In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery","volume":"25","author":"Garanto","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib91","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/02713689408999893","article-title":"A paired comparison of two models of experimental retinal ischemia","volume":"13","author":"Gehlbach","year":"1994","journal-title":"Curr. Eye Res."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib92","first-page":"1694","article-title":"Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements","volume":"46","author":"Ghasemi","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110416_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1634\/theoncologist.1-1-82","article-title":"Drug resistance","volume":"1","author":"Giaccone","year":"1996","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000076105","article-title":"The zebrafish as a model organism for eye development","volume":"36","author":"Glass","year":"2004","journal-title":"Ophthalmic Res."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib95","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.freeradbiomed.2007.12.023","article-title":"Prematurely senescent ARPE-19 cells display features of age-related macular degeneration","volume":"44","author":"Glotin","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2025.110416_bib96","article-title":"Intravitreal galactose conjugated polymeric nanoparticles of etoposide for retinoblastoma","volume":"61","author":"Godse","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.12.6.14","article-title":"Description of a nonhuman primate model of retinal Ischemia\/reperfusion injury","volume":"12","author":"Gong","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib98","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2006.08.014","article-title":"Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme","volume":"84","author":"Gorbatyuk","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100111","article-title":"Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: proof-of-concept investigation","volume":"3","author":"Gore","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib100","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1038\/s41598-021-84574-2","article-title":"Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models","volume":"11","author":"Gozawa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110416_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000431128","article-title":"Retinal anatomy and pathology","volume":"55","author":"Gupta","year":"2016","journal-title":"Retinal Pharmacotherapeutics"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/nyas.14514","article-title":"A rabbit model for evaluating ocular damage from acrolein toxicity in vivo","volume":"1480","author":"Gupta","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075666","article-title":"Recombinant AAV-mediated BEST1 transfer to the retinal pigment epithelium: analysis of serotype-dependent retinal effects","volume":"8","author":"Guziewicz","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/17460441.2019.1551873","article-title":"Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling","volume":"14","author":"Haderspeck","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib105","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib106","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1167\/iovs.12-10959","article-title":"Retinal angiogenesis in the Ins2Akita mouse model of diabetic retinopathy","volume":"54","author":"Han","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101145","article-title":"AAV2-antiVEGFscFv gene therapy for retinal neovascularization","volume":"31","author":"Han","year":"2023","journal-title":"Molecular Therapy-Methods & Clinical Development"},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib108","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal Aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib109","first-page":"3206","article-title":"Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with uveitis: visual and anatomic outcomes by age","volume":"63","author":"Henry","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2011.08.018","article-title":"Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs","volume":"8","author":"Holden","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib111","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bjophthalmol-2012-301504","article-title":"VEGF trap-eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study","volume":"97","author":"Holz","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib112","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/ph14080716","article-title":"Zebrafish model in ophthalmology to study disease mechanism and drug discovery","volume":"14","author":"Hong","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.exer.2025.110416_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-2-2","article-title":"Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina","volume":"2","author":"Horbinski","year":"2001","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.exer.2025.110416_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/917375","article-title":"Combined tractional and rhegmatogenous retinal detachment in proliferative diabetic retinopathy in the Anti-VEGF era","volume":"2014","author":"Hsu","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgg.2024.12.012","article-title":"In vivo adenine base editing ameliorates rho-associated autosomal dominant retinitis pigmentosa","author":"Hu","year":"2024","journal-title":"Journal of Genetics and Genomics"},{"key":"10.1016\/j.exer.2025.110416_bib116","article-title":"Generation of an induced pluripotent stem cell line from a patient with Stargardt disease caused by biallelic c.[5461\u201310T> C; 5603A> T];[6077T> C] mutations in the ABCA4 gene","volume":"54","author":"Huang","year":"2021","journal-title":"Stem Cell Res."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib117","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/biology10121328","article-title":"Therapeutic effects of fenofibrate nano-emulsion eye drops on retinal vascular leakage and neovascularization","volume":"10","author":"Huang","year":"2021","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/10430349950018887","article-title":"Suicide gene therapy for treatment of retinoblastoma in a murine model","volume":"10","author":"Hurwitz","year":"1999","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib119","first-page":"75","article-title":"Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model","volume":"19","author":"Ideno","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib120","first-page":"2406","article-title":"An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor \u03b1 receptor","volume":"43","author":"Ikuno","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib121","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1167\/iovs.15-17703","article-title":"Targeting the Nrf2 signaling pathway in the retina with a gene-delivered secretable and cell-penetrating peptide","volume":"57","author":"Ildefonso","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"16","key":"10.1016\/j.exer.2025.110416_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164717","article-title":"Subretinal injection techniques for retinal disease: a review","volume":"11","author":"Irigoyen","year":"2022","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib123","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ophtha.2005.03.013","article-title":"Long-term Follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis","volume":"112","author":"Jaffe","year":"2005","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202100154","article-title":"Degenerative disease\u2010on\u2010a\u2010chip: developing microfluidic models for rapid availability of newer therapies","volume":"16","author":"Jahagirdar","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.exer.2025.110416_bib125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jmgm.2017.12.023","article-title":"Exploring the association of rs10490924 polymorphism with age-related macular degeneration: an in silico approach","volume":"80","author":"Jahanfar","year":"2018","journal-title":"J. Mol. Graph. Model."},{"issue":"42","key":"10.1016\/j.exer.2025.110416_bib126","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9\u2013based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib127","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/mt.2008.57","article-title":"Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-deficient mouse","volume":"16","author":"Janssen","year":"2008","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcp.21566","article-title":"Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1\u03b1 and VEGF","volume":"218","author":"Jiang","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2025.110416_bib129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2017.09.023","article-title":"Discerning the composition of penetratin for safe penetration from cornea to retina","volume":"63","author":"Jiang","year":"2017","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5966\/sctm.2012-0005","article-title":"Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling","volume":"1","author":"Jin","year":"2012","journal-title":"Stem Cells Transl. Med."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib131","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1080\/15548627.2015.1061170","article-title":"The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells","volume":"11","author":"Johansson","year":"2015","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib133","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.visres.2009.08.028","article-title":"Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin","volume":"50","author":"Johnson","year":"2010","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2025.110416_bib134","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exer.2016.03.018","article-title":"Retinal remodeling in human retinitis pigmentosa","volume":"150","author":"Jones","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ophtha.2012.02.003","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study","volume":"119","author":"Kaiser","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110416_bib136","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1097\/IAE.0b013e31825bc20a","article-title":"Pathology of epiretinal membrane, idiopathic macular hole, and vitreomacular traction syndrome","volume":"32","author":"Kampik","year":"2012","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib137","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17425247.5.9.1039","article-title":"Iluvien\u2122: a new sustained delivery technology for posterior eye disease","volume":"5","author":"Kane","year":"2008","journal-title":"Expet Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib138","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archophthalmol.2009.185","article-title":"Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma","volume":"127","author":"Kang","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib139","article-title":"Carnosic acid slows photoreceptor degeneration in the Pde6b rd10 mouse model of retinitis pigmentosa","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Kang-Mieler","year":"2020","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib141","first-page":"471","article-title":"Analysis of emboli and blood flow in the ophthalmic artery to understand retinal artery occlusion","volume":"59","author":"Kaufmann","year":"2014","journal-title":"Biomedical Engineering\/Biomedizinische Technik"},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib142","first-page":"2856","article-title":"Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo","volume":"42","author":"Kee","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9600","key":"10.1016\/j.exer.2025.110416_bib143","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.exer.2025.110416_bib144","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1039\/b903720a","article-title":"Neuro-optical microfluidic platform to study injury and regeneration of single axons","volume":"9","author":"Kim","year":"2009","journal-title":"Lab Chip"},{"key":"10.1016\/j.exer.2025.110416_bib145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","article-title":"Hydrogels in ophthalmic applications","volume":"95","author":"Kirchhof","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib146","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jnr.20183","article-title":"Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors","volume":"77","author":"Klassen","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007467","article-title":"A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat m\u00fcller cells","volume":"4","author":"Klimczak","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib148","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/vop.12291","article-title":"Sudden acquired retinal degeneration syndrome (SARDS)\u2013A review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy","volume":"19","author":"Kom\u00e1romy","year":"2016","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib149","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"19","key":"10.1016\/j.exer.2025.110416_bib150","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/gt.2008.78","article-title":"Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy","volume":"15","author":"Kong","year":"2008","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib151","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/stem.3239","article-title":"Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapies","volume":"38","author":"Kruczek","year":"2020","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib152","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/bjophthalmol-2020-317712","article-title":"Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease","volume":"106","author":"Kubota","year":"2022","journal-title":"Br. J. Ophthalmol."},{"year":"2022","series-title":"Tools and Data Towards Supporting Quantitative Systems Pharmacology of the eye\u2013an Overview","author":"Kuepfer","key":"10.1016\/j.exer.2025.110416_bib153"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib154","first-page":"288","article-title":"Quantitative systems pharmacology of the eye","volume":"12","author":"Kuepfer","year":"2023","journal-title":"Tools and data for ocular QSP. CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib155","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/7.12.1893","article-title":"Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration","volume":"7","author":"Kumar-Singh","year":"1998","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib156","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.05.033","article-title":"New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis","volume":"139","author":"Lajavardi","year":"2009","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib157","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jgm.1083","article-title":"Helper\u2010dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy","volume":"9","author":"Lamartina","year":"2007","journal-title":"J. Gene Med.: A cross\u2010disciplinary journal for research on the science of gene transfer and its clinical applications"},{"key":"10.1016\/j.exer.2025.110416_bib158","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.omtm.2023.08.012","article-title":"Dual-AAV vector-mediated expression of <em>MYO7A<\/em> improves vestibular function in a mouse model of Usher syndrome 1B","volume":"30","author":"Lau","year":"2023","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/j.exer.2025.110416_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2023.102425","article-title":"Integrating network pharmacology: the next-generation approach in ocular drug discovery","volume":"74","author":"Lazzara","year":"2024","journal-title":"Curr. Opin. Pharmacol."},{"issue":"25","key":"10.1016\/j.exer.2025.110416_bib160","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/sj.gt.3302122","article-title":"In vivo adenovirus-mediated delivery of a uPA\/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy","volume":"10","author":"Le Gat","year":"2003","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib161","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/stem.2010","article-title":"Concise review: making stem cells retinal: methods for deriving retinal pigment epithelium and implications for patients with ocular disease","volume":"33","author":"Leach","year":"2015","journal-title":"Stem Cell."},{"issue":"18","key":"10.1016\/j.exer.2025.110416_bib162","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.gt.3302791","article-title":"AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells","volume":"13","author":"Leaver","year":"2006","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000314","article-title":"XIAP protection of photoreceptors in animal models of retinitis pigmentosa","volume":"2","author":"Leonard","year":"2007","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib164","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1167\/iovs.02-0646","article-title":"A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection","volume":"44","author":"Levkovitch-Verbin","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.eye.6700202","article-title":"Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery","volume":"16","author":"Lewis","year":"2002","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib166","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/mt.2013.232","article-title":"Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone\u2013rod dystrophy","volume":"22","author":"Lh\u00e9riteau","year":"2014","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib167","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.10-6138","article-title":"Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis","volume":"52","author":"Li","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib168","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.colsurfb.2015.12.053","article-title":"Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium","volume":"140","author":"Li","year":"2016","journal-title":"Colloids and Surfaces B: Biointerfaces."},{"issue":"21","key":"10.1016\/j.exer.2025.110416_bib169","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/hmg\/ddq341","article-title":"Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells","volume":"19","author":"Liao","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib170","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3892\/ijmm.2017.3102","article-title":"Regulated differentiation of WERI-Rb-1 cells into retinal neuron-like cells","volume":"40","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib171","doi-asserted-by":"crossref","first-page":"bio048736","DOI":"10.1242\/bio.048736","article-title":"A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression","volume":"9","author":"Liu","year":"2020","journal-title":"Biology open"},{"key":"10.1016\/j.exer.2025.110416_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175215","article-title":"Integrating network pharmacology, transcriptomics, and molecular simulation to reveal the mechanism of tert-butylhydroquinone for treating diabetic retinopathy","volume":"931","author":"Liu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib173","doi-asserted-by":"crossref","first-page":"117","DOI":"10.12988\/ces.2014.31064","article-title":"A method for the detection of diabetic retinopathy by analyzing the image of the retinal vascular network","volume":"7","author":"Luna-Benoso","year":"2014","journal-title":"Contemporary Engineering Sciences"},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib174","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/cell.2012.0076","article-title":"Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis","volume":"15","author":"Lustremant","year":"2013","journal-title":"Cell. Reprogr."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib176","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.ajpath.2017.06.007","article-title":"Impaired rhodopsin generation in the rat model of diabetic retinopathy","volume":"187","author":"Malechka","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib177","first-page":"275","article-title":"Retinal phototransduction","volume":"19","author":"Mannu","year":"2014","journal-title":"Neurosciences Journal"},{"key":"10.1016\/j.exer.2025.110416_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.11","article-title":"Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice","volume":"3","author":"Marangoni","year":"2016","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib179","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.exer.2004.06.023","article-title":"Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide","volume":"79","author":"Marano","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib180","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6900","article-title":"Accuracy of a deep convolutional neural network in detection of retinitis pigmentosa on ultrawide-field images","volume":"7","author":"Masumoto","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.exer.2025.110416_bib181","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/364924","article-title":"Primary retinal cultures as a tool for modeling diabetic retinopathy: an overview","volume":"2015","author":"Matteucci","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib182","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2025.110416_bib183","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exer.2014.01.010","article-title":"Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture","volume":"126","author":"Mazzoni","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib184","doi-asserted-by":"crossref","DOI":"10.4137\/JEN.S5006","article-title":"Time course analysis of gene expression patterns in zebrafish eye during optic nerve regeneration","volume":"4","author":"McCurley","year":"2010","journal-title":"J. Exp. Neurosci."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib185","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1167\/iovs.11-9390","article-title":"Shape change of the vitreous chamber influences retinal detachment and reattachment processes: is mechanical stress during eye rotations a factor?","volume":"53","author":"Meskauskas","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"year":"2014","series-title":"Gene Therapy Restores Vision and Delays Degeneration in the CNGB1\u2212\/\u2212 Mouse Model of Retinitis Pigmentosa. Retinal Degenerative Diseases: Mechanisms and Experimental Therapy","key":"10.1016\/j.exer.2025.110416_bib186"},{"volume":"vol. 2010","first-page":"2","year":"2010","key":"10.1016\/j.exer.2025.110416_bib187"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib188","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/hum.2010.132","article-title":"Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models","volume":"22","author":"Miyazaki","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2025.110416_bib189","first-page":"746","article-title":"Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene","volume":"13","author":"Mo","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2025.110416_bib190","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis","author":"Mohamed","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib191","first-page":"349","article-title":"Effect of high-intensity light on the retinal pigment epithelium of zebrafish\u2013An induced retinal damage study model","volume":"10","author":"Mohesh","year":"2020","journal-title":"Natl. J. Physiol. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib192","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/10717544.2018.1440664","article-title":"New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies","volume":"25","author":"Moon","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib193","first-page":"1","article-title":"Current trends in gene therapy for retinal diseases","volume":"23","author":"Moraru","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.exer.2025.110416_bib194","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0079-6123(08)01121-7","article-title":"Rat models for glaucoma research","volume":"173","author":"Morrison","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib195","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/acsbiomaterials.3c00326","article-title":"Generation of a 3D outer blood\u2013retinal barrier with advanced choriocapillaris and its application in diabetic retinopathy in a microphysiological system","volume":"9","author":"Nam","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib196","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1167\/iovs.02-0595","article-title":"Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog","volume":"44","author":"Narfstr\u04e7m","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib197","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jfluidstructs.2018.06.020","article-title":"A simple mathematical model of rhegmatogenous retinal detachment","volume":"82","author":"Natali","year":"2018","journal-title":"J. Fluid Struct."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib198","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2007.05.062","article-title":"A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema","volume":"114","author":"Network","year":"2007","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib199","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/cells12071071","article-title":"Ocular delivery of therapeutic agents by cell-penetrating peptides","volume":"12","author":"Nh\u00e0n","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/biom11010078","article-title":"Zebrafish models of photoreceptor dysfunction and degeneration","volume":"11","author":"Noel","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2025.110416_bib201","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2019.02.018","article-title":"Blue light exacerbates and red light counteracts negative insults to retinal ganglion cells in situ and R28 cells in vitro","volume":"125","author":"N\u00fa\u00f1ez-\u00c1lvarez","year":"2019","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib202","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.exer.2025.110416_bib204","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.msec.2017.04.068","article-title":"Non-viral strategies for ocular gene delivery","volume":"77","author":"Oliveira","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib205","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/02713683.2017.1302590","article-title":"In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system","volume":"42","author":"Osswald","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"16","key":"10.1016\/j.exer.2025.110416_bib206","article-title":"Matrix metalloproteinase-3 (MMP-3)\u2013mediated gene therapy for glaucoma","volume":"9","author":"O'Callaghan","year":"2023","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib207","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/hum.2009.119","article-title":"Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene","volume":"21","author":"Palfi","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2025.110416_bib208","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fnins.2020.00891","article-title":"AAV-delivered Tulp1 supplementation therapy targeting photoreceptors provides minimal benefit in Tulp1\u2212\/\u2212 retinas","volume":"14","author":"Palfi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110416_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2021.110234","article-title":"Computational and experimental analysis of a glaucoma flat drainage device","volume":"118","author":"Panduro","year":"2021","journal-title":"J. Biomech."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ymthe.2005.09.001","article-title":"Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 leber congenital amaurosis","volume":"13","author":"Pang","year":"2006","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib211","doi-asserted-by":"crossref","first-page":"ORSFj1","DOI":"10.1167\/iovs.15-17594","article-title":"Cell therapy applications for retinal vascular diseases: diabetic retinopathy and retinal vein occlusion","volume":"57","author":"Park","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib212","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40123-014-0024-9","article-title":"Antioxidants improve the viability of stored adult retinal pigment epithelial-19 cultures","volume":"3","author":"Pasovic","year":"2014","journal-title":"Ophthalmology and Therapy"},{"key":"10.1016\/j.exer.2025.110416_bib213","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1208\/aapsj070109","article-title":"DNA-based therapeutics and DNA delivery systems: a comprehensive review","volume":"7","author":"Patil","year":"2005","journal-title":"AAPS J."},{"article-title":"The modelling of glaucoma progression through the use of cellular automata","year":"2013","series-title":"Advances in Intelligent Data Analysis XII: 12Th International Symposium, IDA 2013, London, UK, October 17-19, 2013 Proceedings 12","key":"10.1016\/j.exer.2025.110416_bib214"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1567201820666230123140249","article-title":"Protein nanoparticles laden in situ gel for topical ocular drug delivery","volume":"21","author":"Pillai","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib216","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjo.2008.141085","article-title":"Intravitreal bevacizumab (avastin\u00ae) for macular oedema secondary to retinal vein occlusion: 12-Month results of a prospective clinical trial","volume":"93","author":"Prager","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib217","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1120672120922444","article-title":"Statin reduces the incidence of diabetic retinopathy and its need for intervention: a systematic review and meta-analysis","volume":"31","author":"Pranata","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib218","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejps.2012.11.009","article-title":"Oligochitosan polyplexes as carriers for retinal gene delivery","volume":"48","author":"Puras","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib219","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41536-019-0081-8","article-title":"Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells (MA09-hRPE) in macular degeneration","volume":"4","author":"Qiu","year":"2019","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.exer.2025.110416_bib220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-4419-1399-9_42","article-title":"Near-infrared light protect the photoreceptor from light-induced damage in rats","author":"Qu","year":"2010","journal-title":"Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib221","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/ddy337","article-title":"Loss of CRB2 in M\u00fcller glial cells modifies a CRB1-associated retinitis pigmentosa phenotype into a Leber congenital amaurosis phenotype","volume":"28","author":"Quinn","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib222","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(02)01322-3","article-title":"Transplantation of intact sheets of fetal neural retina with its retinal pigment epithelium in retinitis pigmentosa patients","volume":"133","author":"Radtke","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108678","article-title":"A nonhuman primate model of blue light-induced progressive outer retina degeneration showing brimonidine drug delivery system-mediated cyto-and neuroprotection","volume":"209","author":"Rajagopalan","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib224","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.exer.2005.10.012","article-title":"Mouse models of age-related macular degeneration","volume":"82","author":"Rakoczy","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"10011","key":"10.1016\/j.exer.2025.110416_bib225","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib226","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1111\/jcmm.14433","article-title":"Loss of retinal ganglion cells in a new genetic mouse model for primary open\u2010angle glaucoma","volume":"23","author":"Reinehr","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib227","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1296-1316","article-title":"Adenovirus\u2013mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+\/\u2212 mice","volume":"2","author":"Riley","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2025.110416_bib228","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.preteyeres.2016.04.001","article-title":"Mathematical and computational models of the retina in health, development and disease","volume":"53","author":"Roberts","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib229","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtbi.2017.05.006","article-title":"Mathematical models of retinitis pigmentosa: the oxygen toxicity hypothesis","volume":"425","author":"Roberts","year":"2017","journal-title":"J. Theor. Biol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1167\/iovs.11-8784","article-title":"Generation of an inbred miniature pig model of retinitis pigmentosa","volume":"53","author":"Ross","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib231","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jconrel.2023.09.021","article-title":"Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration","volume":"363","author":"Ruiz","year":"2023","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib232","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.exer.2005.03.014","article-title":"The pig eye as a novel model of glaucoma","volume":"81","author":"Ruiz-Ederra","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib233","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0161-6420(95)30850-0","article-title":"Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene: can proliferative vitreoretinopathy be a target of gene therapy?","volume":"102","author":"Sakamoto","year":"1995","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib234","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1248\/bpb.31.1590","article-title":"Ocular pharmacokinetic\/pharmacodynamic modeling for multiple anti-glaucoma drugs","volume":"31","author":"Sakanaka","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib235","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib236","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1167\/iovs.16-19087","article-title":"Stem cell\u2013derived photoreceptor transplants differentially integrate into mouse models of cone-rod dystrophy","volume":"57","author":"Santos-Ferreira","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100880","article-title":"Retina in a dish: cell cultures, retinal explants and animal models for common diseases of the retina","volume":"81","author":"Schnichels","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib238","first-page":"1336","article-title":"Stargardt disease ALK-001 phase 2 clinical trial: 12-month interim data","volume":"60","author":"Scholl","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib239","first-page":"1773","article-title":"Pores of the internal limiting membrane: a common finding in vitreomaculopathies","volume":"43","author":"Schumann","year":"2023","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib240","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"Scott","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib241","series-title":"Biology and Diseases of the Ferret","first-page":"711","article-title":"The ferret as a model for visual system development and plasticity","author":"Sharma","year":"2014"},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib242","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1167\/iovs.13-13650","article-title":"Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood\u2013retinal barrier breakdown","volume":"55","author":"Shen","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib243","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(00)00426-4","article-title":"Antagonistic and synergistic effects of combined treatment with interleukin-2 and interleukin-4 on mixed retinal cell cultures","volume":"113","author":"Sholl-Franco","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib244","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ajcn\/69.4.656","article-title":"Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa2","volume":"69","author":"Sibulesky","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib245","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1167\/iovs.18-26251","article-title":"Steinbach-rankins JM. Surface-modified melphalan nanoparticles for intravitreal chemotherapy of retinoblastoma","volume":"60","author":"Sims","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib246","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/wnan.1328","article-title":"Nanogels for delivery, imaging and therapy","volume":"7","author":"Sivaram","year":"2015","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"issue":"20","key":"10.1016\/j.exer.2025.110416_bib247","doi-asserted-by":"crossref","first-page":"11706","DOI":"10.1073\/pnas.1934712100","article-title":"Genetically engineered mice with an additional class of cone photoreceptors: implications for the evolution of color vision","volume":"100","author":"Smallwood","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib248","first-page":"1429","volume":"vol. 245","author":"Stahl","year":"2007"},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib249","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/archopht.1992.01080230134038","article-title":"Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa","volume":"110","author":"Stone","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110416_bib250","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.939774","article-title":"Retinal organoids and microfluidic chip-based approaches to explore the retinitis pigmentosa with USH2A mutations","volume":"10","author":"Su","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.exer.2025.110416_bib251","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2019.05.003","article-title":"Nucleic acid delivery to differentiated retinal pigment epithelial cells using cell-penetrating peptide as a carrier","volume":"140","author":"Subia","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2025.110416_bib252","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajo.2020.06.020","article-title":"Determining the tractional forces on vitreoretinal interface using a computer simulation model in abusive head trauma","volume":"223","author":"Suh","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib253","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/02713683.2012.663854","article-title":"Primary vitrectomy versus scleral buckling for the treatment of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled clinical trials","volume":"37","author":"Sun","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2025.110416_bib254","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtn.2017.02.005","article-title":"Targeted multifunctional lipid ECO plasmid DNA nanoparticles as efficient non-viral gene therapy for leber's congenital amaurosis","volume":"7","author":"Sun","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib255","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00210-022-02287-3","article-title":"Nanomedicine and drug delivery to the retina: current status and implications for gene therapy","volume":"395","author":"Tawfik","year":"2022","journal-title":"Naunyn-schmiedeberg's Archives of Pharmacology"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib256","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101562RR","article-title":"Prph2 disease mutations lead to structural and functional defects in the RPE","volume":"36","author":"Tebbe","year":"2022","journal-title":"FASEB J.: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib257","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib258","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib259","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1167\/iovs.06-1501","article-title":"Restoration of visual response in aged dystrophic RCS rats using AAV-Mediated channelopsin-2 gene transfer","volume":"48","author":"Tomita","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2\u20133","key":"10.1016\/j.exer.2025.110416_bib260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","article-title":"Structure and design of polymeric surfactant-based drug delivery systems","volume":"73","author":"Torchilin","year":"2001","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib261","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2011.304","article-title":"Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina","volume":"20","author":"Touchard","year":"2012","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib262","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41434-020-0174-4","article-title":"Large gene delivery to the retina with AAV vectors: are we there yet?","volume":"28","author":"Trapani","year":"2021","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib263","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bjo.2003.033894","article-title":"Conditioned medium from mixed retinal pigmented epithelium and m\u00fcller cell cultures reduces in vitro permeability of retinal vascular endothelial cells","volume":"88","author":"Tretiach","year":"2004","journal-title":"The British Journal of Ophthalmology"},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib264","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/ceo.12992","article-title":"DBA\/2J mouse model for experimental glaucoma: pitfalls and problems","volume":"45","author":"Turner","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108071","article-title":"Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications","volume":"9","author":"Ueyama","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2025.110416_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2023.103100","article-title":"Generation and characterization of a human iPSC line (JUFMDOi007-A) from a patient with Usher syndrome due to mutation in USH2A","volume":"69","author":"Ukaji","year":"2023","journal-title":"Stem Cell Res."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib267","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11082170","article-title":"Mesoporous silica-based nanoparticles as non-viral gene delivery platform for treating retinitis pigmentosa","volume":"11","author":"Vald\u00e9s-S\u00e1nchez","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib268","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bjophthalmol-2020-318483","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: current management and clinical trials","volume":"106","author":"Varela","year":"2022","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib269","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2013.07.014","article-title":"The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments","volume":"50","author":"Varshochian","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib270","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1016\/j.jksuci.2021.02.003","article-title":"A novel optic disc and optic cup segmentation technique to diagnose glaucoma using deep learning convolutional neural network over retinal fundus images","volume":"34","author":"Veena","year":"2022","journal-title":"Journal of King Saud University-Computer and Information Sciences"},{"key":"10.1016\/j.exer.2025.110416_bib271","article-title":"Physics-based modeling of age-related macular degeneration\u2014a theoretical approach to quantify retinal and choroidal contributions to macular oxygenation","volume":"339","author":"Vercellin","year":"2021","journal-title":"Math. Biosci."},{"year":"2019","series-title":"The Effects of AAV-mediated XIAP Gene Therapy in a Mouse Model of Glaucoma: Universit\u00e9 D","author":"Visuvanathan","key":"10.1016\/j.exer.2025.110416_bib272"},{"issue":"22","key":"10.1016\/j.exer.2025.110416_bib273","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.221364198","article-title":"Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of <i>Mertk<\/i>","volume":"98","author":"Vollrath","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib274","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3892\/mmr.2015.4054","article-title":"Gene therapy for ocular diseases meditated by ultrasound and microbubbles","volume":"12","author":"Wan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib275","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1582-4934.2009.00786.x","article-title":"Cell\u2010penetrating peptide TAT\u2010mediated delivery of acidic FGF to retina and protection against ischemia\u2013reperfusion injury in rats","volume":"14","author":"Wang","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib276","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bm2009558","article-title":"Extended release of Bevacizumab by thermosensitive biodegradable and biocompatible hydrogel","volume":"13","author":"Wang","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.exer.2025.110416_bib277","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2014.04.028","article-title":"Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells","volume":"191","author":"Wang","year":"2014","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib278","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1167\/iovs.16-19447","article-title":"RhoA signaling and synaptic damage occur within hours in a live pig model of CNS injury, retinal detachment","volume":"57","author":"Wang","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"20","key":"10.1016\/j.exer.2025.110416_bib279","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","article-title":"Mouse \u03b3-Synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells","volume":"40","author":"Wang","year":"2020","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib280","doi-asserted-by":"crossref","DOI":"10.1038\/srep45329","article-title":"Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection","volume":"7","author":"Wassmer","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107939","article-title":"Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration","volume":"26","author":"Wei-Zhang","year":"2023","journal-title":"iScience"},{"issue":"17","key":"10.1016\/j.exer.2025.110416_bib282","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/ijms21176262","article-title":"Neuroprotection of retinal ganglion cells with AAV2-BDNF pretreatment restoring normal TrkB receptor protein levels in glaucoma","volume":"21","author":"W\u00f3jcik-Gryciuk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110416_bib283","first-page":"41","volume":"vol. 251","author":"Woo","year":"2013"},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib284","first-page":"5","article-title":"Streptozotocin\u2010induced diabetic models in mice and rats","volume":"40","author":"Wu","year":"2008","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.exer.2025.110416_bib285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-012-0005-9","article-title":"Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study","volume":"1","author":"Yamamoto","year":"2012","journal-title":"Ophthalmology and therapy"},{"key":"10.1016\/j.exer.2025.110416_bib286","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.omtn.2023.08.002","article-title":"Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice","volume":"33","author":"Yan","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"9","key":"10.1016\/j.exer.2025.110416_bib287","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/nn301873v","article-title":"Hybrid dendrimer Hydrogel\/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib288","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/jps.24588","article-title":"In Vitro\/In vivo evaluation of Dexamethasone\u2014Pamam dendrimer complexes for retinal drug delivery","volume":"104","author":"Yavuz","year":"2015","journal-title":"J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110416_bib289","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1167\/iovs.15-16805","article-title":"Artificial neural network approach for differentiating open-angle glaucoma from glaucoma suspect without a visual field test","volume":"56","author":"Yoo","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2025.110416_bib290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105461","article-title":"The rax homeoprotein in m\u00fcller glial cells is required for homeostasis maintenance of the postnatal mouse retina","volume":"299","author":"Yoshimoto","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.exer.2025.110416_bib291","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.2.5","article-title":"Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: a 6-month in vivo study","volume":"4","author":"Yu","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.exer.2025.110416_bib292","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14716","article-title":"Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.exer.2025.110416_bib293","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archophthalmol.2009.265","article-title":"Preclinical evaluation of the novel small-molecule integrin \u03b15\u03b21 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization","volume":"127","author":"Zahn","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib294","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094272","article-title":"EIAV-based retinal gene therapy in the shaker1 mouse model for Usher syndrome type 1B: development of UshStat","volume":"9","author":"Zallocchi","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.exer.2025.110416_bib295","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/sctm.18-0282","article-title":"Concise review: update on retinal pigment epithelium transplantation for age-related macular degeneration","volume":"8","author":"Zarbin","year":"2019","journal-title":"Stem Cells Transl. Med."},{"issue":"11","key":"10.1016\/j.exer.2025.110416_bib296","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0161-6420(93)31423-5","article-title":"Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model","volume":"100","author":"Zeng","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110416_bib297","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119811","article-title":"Spontaneous fundus lesions in elderly monkeys: an ideal model for age-related macular degeneration and high myopia clinical research","volume":"282","author":"Zeng","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.exer.2025.110416_bib298","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/11206721211020200","article-title":"Circ_0000615 promotes high glucose-induced human retinal pigment epithelium cell apoptosis, inflammation and oxidative stress via miR-646\/YAP1 axis in diabetic retinopathy","volume":"32","author":"Zeng","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2025.110416_bib299","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1046-2023(02)00263-3","article-title":"Tissue culture studies of retinal development","volume":"28","author":"Zhang","year":"2002","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.exer.2025.110416_bib300","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1167\/iovs.09-4373","article-title":"Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes","volume":"51","author":"Zhang","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2025.110416_bib301","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/jbm.a.36417","article-title":"Viscoelastic properties of the posterior eye of normal subjects, patients with age-related macular degeneration, and pigs","volume":"106","author":"Zhang","year":"2018","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.exer.2025.110416_bib302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13619-021-00097-1","article-title":"Retinal organoids as models for development and diseases","volume":"10","author":"Zhang","year":"2021","journal-title":"Cell Regen."},{"key":"10.1016\/j.exer.2025.110416_bib303","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1132179","article-title":"Rhodopsin-associated retinal dystrophy: disease mechanisms and therapeutic strategies","volume":"17","author":"Zhen","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110416_bib304","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fcell.2018.00075","article-title":"Versatile genome engineering techniques advance human ocular disease researches in zebrafish","volume":"6","author":"Zheng","year":"2018","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:11:07Z","timestamp":1747944667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":304,"alternative-id":["S0014483525001873"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110416","relation":{},"ISSN":["0014-4835"],"issn-type":[{"type":"print","value":"0014-4835"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances on modeling retinal disease: Towards efficient gene\/drug therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110416"}}